Streptomyces-Derived Nano-Doxorubicin: Clinical Status and Patents Granted

    January 2024 in “ Scripta Medica
    Prabhjot Kaur, Divya Dhawal Bhandari, Hitesh Chopra
    TLDR Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.
    Streptomyces-derived doxorubicin (DOX) is a widely used anti-cancer drug effective against various cancers but is limited by significant adverse effects such as nausea, vomiting, alopecia, and cardiotoxicity. Nanoparticle delivery systems offer a promising solution to mitigate these side effects, with some formulations already in clinical use and others showing potential in development. This review emphasizes the importance of integrating nanotechnology with Streptomyces-derived compounds to enhance anti-cancer therapies, highlighting the current clinical status and the need for further development of multifunctional nanoparticles.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    1 / 1 results

      community Stopping finasteride for chemo

      in Finasteride/Dutasteride  108 upvotes 1 year ago
      A user diagnosed with lymphoma is advised to stop finasteride during chemotherapy, with suggestions to consider treatments like Dutasteride and Minoxidil post-recovery. The focus is on prioritizing health over hair loss, with encouragement and advice from others who have experienced similar situations.

    Similar Research

    5 / 775 results